Figure 1.

Plasma levels of platelet activation markers before and after implantation of a CF-LVAD Plasma levels of platelet activation marker β-thromboglobulin (A) and soluble P-selectin (B) were measured in the plasma samples from patients with end-stage heart failure before (pre) and after (post) LVAD implantation (n = 32) and in healthy controls (HC, n = 28) with enzyme-linked immunosorbent assay. Data are presented as median and interquartile ranges. βTG, β-thromboglobulin; sP-selectin, soluble P-selectin